Biotechnologists have developed a system to accurately measure muscle weakness caused by structural changes in muscle tissue. The new method allows muscle function to be assessed using imaging without the need for sophisticated biomechanical recordings, and could in future even make taking tissue samples for diagnosing myopathy superfluous.